secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harvard Apparatus Regenerative Technology, Inc. (HRGN)
CIK:        0001563665
Form:       8-K
Filed at:   2023-04-10T23:59:59+00:00
Accession:  0001493152-23-011655
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biostage appoints Ron Packard, CEO of Pansophic Learning, to Board of Directors
-------------------------------------------------------------------------------

- Ron Packard appointed as Class II director effective April 5, 2023; term until 2024 annual meeting.
- Receives stock options valued at $25,000 vesting quarterly over one year; also standard non-employee director compensation ($20,000 cash + $25,000 annual option grant).
- Packard is CEO/Founder of Pansophic Learning, former CEO/Founder of K12 Inc., which he grew to ~$1B revenue and led through NYSE IPO.
- Previous roles include McKinsey & Company (biotech/semiconductors), Goldman Sachs (M&A), and holds CFA designation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563665/000149315223011655/0001493152-23-011655-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563665/000149315223011655/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-011655

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer